例如:"NBL1", "4681", "drought"
收藏
140497 Cd300c2

140497

Cd300c2

CD300C molecule 2

protein-coding

Mus musculus

基因描述

Type Description
Definition CD300C molecule 2

研究结论

Date Results Publications
2020-05-30 10:14:00 Our findings demonstrate that CD300c2 contributes to BLM-induced inflammatory responses mediated by alveolar macrophages. 31757863
2016-03-12 11:04:00 Toll-like receptor 4 and MAIR-II/CLM-4/LMIR2 immunoreceptor regulate VLA-4-mediated inflammatory monocyte migration. 25134989
2011-10-22 10:59:00 DAP12-coupled MAIR-II negatively regulates B cell-mediated adaptive immune responses. 21727189
2010-01-21 00:00:00 Molecular cloning and characterization of leukocyte mono-immunoglobulin-like receptor1 and 2 derived from mast cells [LMIR1] [LMIR2] 12893283
2010-01-21 00:00:00 FcRgamma chain may provide cooperation with and/or compensation for DAP12 in MAIR-II-mediated inflammatory responses by peritoneal macrophages 17202337

名称对应

Type IDs
Synonymous CLM4, Cd300c, Cd300d, DIgR1, Igsf7, Lmir2, MAIR-II
Gene
UniProtKB-ID: CLM4_MOUSE
UniprotKB: Q7TSN2
UniParc: UPI000002964E
EMBL: BC006801, AB091768, AL607025, AY457050, AB098476, AB091767
Ensembl: ENSMUSG00000044811
KO: mmu:140497
Nucleutide sequences
EMBL-CDS: BAC77077.1, BAC77076.1, BAC80269.1, AAR27941.1, AAH06801.1
Ensembl_TRS: ENSMUST00000092464
Protein sequencees
Ensembl_PRO: ENSMUSP00000090121
RefSeq: NP_598919.1
Others
UniRef100: UniRef100_Q7TSN2
UniRef90: UniRef90_Q7TSN2
UniRef50: UniRef50_Q7TSN2
UniGene: Mm.2699
CCDS: CCDS25616.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员